Taiwan Today
Date: February 5, 2016

ROC President Ma Ying-jeou said Feb. 4 that the government is

President Ma Ying-jeou (right) greets winners of the National Biotechnology and Medical Care Quality Awards at the Presidential Office Feb. 4 in Taipei City. (CNA)

ramping up efforts to develop Taiwan’s biotechnology and medical care sectors, eyeing NT$4 trillion (US$120.4 billion) in total production by 2025.

“Biotechnology is set to become a major growth engine for the local economy in the years ahead, building on Bio Taiwan Committee’s comprehensive promotion plan spanning areas like agriculture, food, health care, medical instruments and pharmaceuticals,” Ma said.

“Capitalizing on cross-sector integration provided by such initiatives as the Taiwan Biotechnology Take-off Diamond Action Plan, our biomedicine revenue topped NT$280 billion in 2014, along with 94 public listed companies by the end of last year.     [FULL  STORY]